Literature DB >> 8934572

Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis.

T Fukada1, M Hibi, Y Yamanaka, M Takahashi-Tezuka, Y Fujitani, T Yamaguchi, K Nakajima, T Hirano.   

Abstract

gp130 is a common signal transducer for the interleukin-6-related cytokines. To delineate the gp130-mediated growth signal, we established a series of pro-B cell lines expressing chimeric receptors composed of the extracellular domain of the granulocyte colony-stimulating factor receptor and the transmembrane and cytoplasmic domains of gp130. The second tyrosine (from the membrane) of gp130, which was required for the tyrosine phosphorylation of SHP-2, its association with GRB2, and activation of a MAP kinase, was essential for mitogenesis, but not for anti-apoptosis. On the other hand, the tyrosine in the YXXQ motifs essential for STAT3 activation was required for bcl-2 induction and anti-apoptosis. Furthermore, dominant-negative STAT3 inhibited anti-apoptosis. These data demonstrate that two distinct signals, mitogenesis and anti-apoptosis, are required for gp130-induced cell growth and that STAT3 is involved in anti-apoptosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8934572     DOI: 10.1016/s1074-7613(00)80501-4

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  153 in total

1.  Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3.

Authors:  R S Chapman; P C Lourenco; E Tonner; D J Flint; S Selbert; K Takeda; S Akira; A R Clarke; C J Watson
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

2.  A single amino acid substitution (Trp(666)-->Ala) in the interbox1/2 region of the interleukin-6 signal transducer gp130 abrogates binding of JAK1, and dominantly impairs signal transduction.

Authors:  C Haan; H M Hermanns; P C Heinrich; I Behrmann
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

3.  Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation.

Authors:  M Itoh; Y Yoshida; K Nishida; M Narimatsu; M Hibi; T Hirano
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 4.  Interleukin 6 and liver regeneration.

Authors:  K L Streetz; T Luedde; M P Manns; C Trautwein
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

5.  K-Ras mediates cytokine-induced formation of E-cadherin-based adherens junctions during liver development.

Authors:  Takaaki Matsui; Taisei Kinoshita; Yoshihiro Morikawa; Kazuo Tohya; Motoya Katsuki; Yoshiaki Ito; Akihide Kamiya; Atsushi Miyajima
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

6.  PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation.

Authors:  T Hirai; T Masaki; M Kuratsune; N Yorioka; N Kohno
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

7.  Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.

Authors:  M Kieslinger; I Woldman; R Moriggl; J Hofmann; J C Marine; J N Ihle; H Beug; T Decker
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

8.  Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway.

Authors:  Dairmuid M Moran; M Adrian Mattocks; Paul A Cahill; Leonidas G Koniaris; Iain H McKillop
Journal:  J Surg Res       Date:  2007-06-14       Impact factor: 2.192

9.  Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies.

Authors:  G Packham; E L White; C M Eischen; H Yang; E Parganas; J N Ihle; D A Grillot; G P Zambetti; G Nuñez; J L Cleveland
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

Review 10.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.